184 related articles for article (PubMed ID: 25875367)
1. Prognostic value of the interaction between galectin-3 and antigen carbohydrate 125 in acute heart failure.
Núñez J; Rabinovich GA; Sandino J; Mainar L; Palau P; Santas E; Villanueva MP; Núñez E; Bodí V; Chorro FJ; Miñana G; Sanchis J
PLoS One; 2015; 10(4):e0122360. PubMed ID: 25875367
[TBL] [Abstract][Full Text] [Related]
2. Differential Prognostic Value of Galectin-3 According to Carbohydrate Antigen 125 Levels in Transcatheter Aortic Valve Implantation.
Rheude T; Pellegrini C; Núñez J; Joner M; Trenkwalder T; Mayr NP; Holdenrieder S; Bodi V; Koenig W; Kasel AM; Schunkert H; Kastrati A; Hengstenberg C; Husser O
Rev Esp Cardiol (Engl Ed); 2019 Nov; 72(11):907-915. PubMed ID: 30482731
[TBL] [Abstract][Full Text] [Related]
3. [Carbohydrate antigen 125 serial measurements after an admission for acute heart failure and risk of early readmission].
Miñana Escrivá G; Núñez J; Sanchis J; Bodi V; Núñez E; Chorro FJ; Llàcer A
Med Clin (Barc); 2012 Nov; 139(11):479-86. PubMed ID: 22093405
[TBL] [Abstract][Full Text] [Related]
4. Differential mortality association of loop diuretic dosage according to blood urea nitrogen and carbohydrate antigen 125 following a hospitalization for acute heart failure.
Núñez J; Núñez E; Miñana G; Bodí V; Fonarow GC; Bertomeu-González V; Palau P; Merlos P; Ventura S; Chorro FJ; Llàcer P; Sanchis J
Eur J Heart Fail; 2012 Sep; 14(9):974-84. PubMed ID: 22700856
[TBL] [Abstract][Full Text] [Related]
5. Long-term serial kinetics of N-terminal pro B-type natriuretic peptide and carbohydrate antigen 125 for mortality risk prediction following acute heart failure.
Núñez J; Núñez E; Bayés-Genís A; Fonarow GC; Miñana G; Bodí V; Pascual-Figal D; Santas E; Garcia-Blas S; Chorro FJ; Rizopoulos D; Sanchis J
Eur Heart J Acute Cardiovasc Care; 2017 Dec; 6(8):685-696. PubMed ID: 27199489
[TBL] [Abstract][Full Text] [Related]
6. Carbohydrate antigen 125: an emerging prognostic risk factor in acute heart failure?
Núñez J; Núñez E; Consuegra L; Sanchis J; Bodí V; Martínez-Brotons A; Bertomeu-González V; Robles R; Bosch MJ; Fácila L; Darmofal H; Llàcer A
Heart; 2007 Jun; 93(6):716-21. PubMed ID: 17164487
[TBL] [Abstract][Full Text] [Related]
7. Estimating systemic fibrosis by combining galectin-3 and ST2 provides powerful risk stratification value for patients after acute decompensated heart failure.
Wang CH; Yang NI; Liu MH; Hsu KH; Kuo LT
Cardiol J; 2016; 23(5):563-572. PubMed ID: 27515479
[TBL] [Abstract][Full Text] [Related]
8. Carbohydrate Antigen-125-Guided Therapy in Acute Heart Failure: CHANCE-HF: A Randomized Study.
Núñez J; Llàcer P; Bertomeu-González V; Bosch MJ; Merlos P; García-Blas S; Montagud V; Bodí V; Bertomeu-Martínez V; Pedrosa V; Mendizábal A; Cordero A; Gallego J; Palau P; Miñana G; Santas E; Morell S; Llàcer A; Chorro FJ; Sanchis J; Fácila L;
JACC Heart Fail; 2016 Nov; 4(11):833-843. PubMed ID: 27522630
[TBL] [Abstract][Full Text] [Related]
9. Carbohydrate antigen 125 predicts long-term mortality in African American patients with acute decompensated heart failure.
Mansour IN; Napan S; Tarek Alahdab M; Stamos TD
Congest Heart Fail; 2010; 16(1):15-20. PubMed ID: 20078623
[TBL] [Abstract][Full Text] [Related]
10. Clinical and prognostic value of elevated CA125 levels in patients with congestive heart failure.
Kouris NT; Kontogianni DD; Papoulia EP; Goranitou GS; Zaharos ID; Grassos HA; Kalkandi EM; Sifaki MD; Babalis DK
Hellenic J Cardiol; 2006; 47(5):269-74. PubMed ID: 17134062
[TBL] [Abstract][Full Text] [Related]
11. [Benefits of statin therapy based on plasma carbohydrate antigen 125 values following an admission for acute heart failure].
Núñez J; Sanchis J; Núñez E; Fonarow GC; Bodí V; Bertomeu-González V; Miñana G; Palau P; Fácila L; Chorro FJ; Bertomeu-Martínez V; Llàcer A
Rev Esp Cardiol; 2011 Dec; 64(12):1100-8. PubMed ID: 21958731
[TBL] [Abstract][Full Text] [Related]
12. Antigen carbohydrate 125 and creatinine on admission for prediction of renal function response following loop diuretic administration in acute heart failure.
Núñez J; Llàcer P; Núñez E; Ventura S; Bonanad C; Bodí V; Miñana G; Santas E; Mascarell B; Fonarow GC; Chorro FJ; Sanchis J
Int J Cardiol; 2014 Jul; 174(3):516-23. PubMed ID: 24801083
[TBL] [Abstract][Full Text] [Related]
13. Procalcitonin and long-term prognosis after an admission for acute heart failure.
Villanueva MP; Mollar A; Palau P; Carratalá A; Núñez E; Santas E; Bodí V; Chorro FJ; Miñana G; Blasco ML; Sanchis J; Núñez J
Eur J Intern Med; 2015 Jan; 26(1):42-8. PubMed ID: 25592074
[TBL] [Abstract][Full Text] [Related]
14. Metabolic profile provides prognostic value better than galectin-3 in patients with heart failure.
Wang CH; Cheng ML; Liu MH; Kuo LT; Shiao MS
J Cardiol; 2017 Jul; 70(1):92-98. PubMed ID: 28318874
[TBL] [Abstract][Full Text] [Related]
15. The prognostic value of plasma galectin-3 in chronic heart failure patients is maintained when treated with mineralocorticoid receptor antagonists.
Koukoui F; Desmoulin F; Galinier M; Barutaut M; Caubère C; Evaristi MF; Murat G; De Boer R; Berry M; Smih F; Rouet P
PLoS One; 2015; 10(3):e0119160. PubMed ID: 25786035
[TBL] [Abstract][Full Text] [Related]
16. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of carbohydrate antigen 125 in patients with chronic heart failure: relation to clinical severity, hemodynamic and Doppler echocardiographic abnormalities, and short-term prognosis.
D'Aloia A; Faggiano P; Aurigemma G; Bontempi L; Ruggeri G; Metra M; Nodari S; Dei Cas L
J Am Coll Cardiol; 2003 May; 41(10):1805-11. PubMed ID: 12767668
[TBL] [Abstract][Full Text] [Related]
18. Tumor marker carbohydrate antigen 125 predicts adverse outcome after transcatheter aortic valve implantation.
Husser O; Núñez J; Núñez E; Holzamer A; Camboni D; Luchner A; Sanchis J; Bodi V; Riegger GA; Schmid C; Hilker M; Hengstenberg C
JACC Cardiovasc Interv; 2013 May; 6(5):487-96. PubMed ID: 23702013
[TBL] [Abstract][Full Text] [Related]
19. Antigen carbohydrate 125 and brain natriuretic peptide serial measurements for risk stratification following an episode of acute heart failure.
Núñez J; Núñez E; Sanchis J; Bodí V; Fonarow GC; Miñana G; Palau P; Bertomeu-González V; Carratalá A; Mainar L; Chorro FJ; Llàcer A
Int J Cardiol; 2012 Aug; 159(1):21-8. PubMed ID: 21367474
[TBL] [Abstract][Full Text] [Related]
20. Clinical Role of CA125 in Worsening Heart Failure: A BIOSTAT-CHF Study Subanalysis.
Núñez J; Bayés-Genís A; Revuelta-López E; Ter Maaten JM; Miñana G; Barallat J; Cserkóová A; Bodi V; Fernández-Cisnal A; Núñez E; Sanchis J; Lang C; Ng LL; Metra M; Voors AA
JACC Heart Fail; 2020 May; 8(5):386-397. PubMed ID: 32171764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
